Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia
Data(s) |
2010
|
---|---|
Resumo |
The kallikreins and kallikrein-related peptidases are serine proteases that control a plethora of developmental and homeostatic phenomena, ranging from semen liquefaction to skin desquamation and blood pressure. The diversity of roles played by kallikreins has stimulated considerable interest in these enzymes from the perspective of diagnostics and drug design. Kallikreins already have well-established credentials as targets for therapeutic intervention and there is increasing appreciation of their potential both as biomarkers and as targets for inhibitor design. Here, we explore the current status of naturally occurring kallikrein protease-inhibitor complexes and illustrate how this knowledge can interface with strategies for rational re-engineering of bioscaffolds and design of small-molecule inhibitors. |
Formato |
application/pdf |
Identificador | |
Publicador |
Walter de Gruyter GmbH and Co. KG |
Relação |
http://eprints.qut.edu.au/42921/1/42921.pdf DOI:10.1515/BC.2010.037 Swedberg, Joakim, De Veer, Simon, & Harris, Jonathan (2010) Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia. Biological Chemistry: official scientific journal of the GBM, 391(4), pp. 357-374. |
Direitos |
Copyright 2010 Walter de Gruyter The final publication is available at www.degruyter.com |
Fonte |
Faculty of Health; Institute of Health and Biomedical Innovation |
Palavras-Chave | #060100 BIOCHEMISTRY AND CELL BIOLOGY #bioscaffold, drug design, inhibitor, phage display, protease positional scanning synthetic combinatorial library, sunflower trypsin inhibitor |
Tipo |
Journal Article |